192 related articles for article (PubMed ID: 17035339)
1. VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3.
Baroni E; Biffi M; Benigni F; Monno A; Carlucci D; Carmeliet G; Bouillon R; D'Ambrosio D
J Leukoc Biol; 2007 Jan; 81(1):250-62. PubMed ID: 17035339
[TBL] [Abstract][Full Text] [Related]
2. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
3. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
[TBL] [Abstract][Full Text] [Related]
4. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
Carcinogenesis; 2005 Feb; 26(2):429-40. PubMed ID: 15539405
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
7. Role of vitamin D3 receptor in the synergistic differentiation of WEHI-3B leukemia cells by vitamin D3 and retinoic acid.
Li J; Finch RA; Sartorelli AC
Exp Cell Res; 1999 Jun; 249(2):279-90. PubMed ID: 10366427
[TBL] [Abstract][Full Text] [Related]
8. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
[TBL] [Abstract][Full Text] [Related]
9. Modulation by cAMP of 1alpha,25-dihydroxyvitamin D3 sensitivity of murine erythroleukemia cells.
Waki M; Inaba M; Hiura Y; Nagasaki T; Imanishi Y; Ishimura E; Otani S; Nishizawa Y
Arch Biochem Biophys; 2001 Jul; 391(2):265-70. PubMed ID: 11437358
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
Buchwald PC; Westin G; Akerström G
Int J Mol Med; 2005 Apr; 15(4):701-6. PubMed ID: 15754035
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor ablation alters skin architecture and homeostasis of dendritic epidermal T cells.
Meindl S; Rot A; Hoetzenecker W; Kato S; Cross HS; Elbe-Bürger A
Br J Dermatol; 2005 Feb; 152(2):231-41. PubMed ID: 15727633
[TBL] [Abstract][Full Text] [Related]
13. Intracellular IL-15 controls mast cell survival.
Mirghomizadeh F; Winoto-Morbach S; Orinska Z; Lee KH; Schütze S; Bulfone-Paus S
Exp Cell Res; 2009 Oct; 315(17):3064-75. PubMed ID: 19632221
[TBL] [Abstract][Full Text] [Related]
14. Human leukemic (HMC-1) mast cells are responsive to 1alpha, 25-dihydroxyvitamin D(3): selective promotion of ICAM-3 expression and constitutive presence of vitamin D(3) receptor.
Babina M; Krautheim M; Grützkau A; Henz BM
Biochem Biophys Res Commun; 2000 Jul; 273(3):1104-10. PubMed ID: 10891379
[TBL] [Abstract][Full Text] [Related]
15. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning.
Yoshizawa T; Handa Y; Uematsu Y; Takeda S; Sekine K; Yoshihara Y; Kawakami T; Arioka K; Sato H; Uchiyama Y; Masushige S; Fukamizu A; Matsumoto T; Kato S
Nat Genet; 1997 Aug; 16(4):391-6. PubMed ID: 9241280
[TBL] [Abstract][Full Text] [Related]
16. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells.
Guerrero R; de la Piedra C; Teixeiro E; Bragado R; Traba ML
J Rheumatol; 2004 Jan; 31(1):167-72. PubMed ID: 14705237
[TBL] [Abstract][Full Text] [Related]
17. Effect of growth and maturation on membrane-initiated actions of 1,25-dihydroxyvitamin D3-II: calcium transport, receptor kinetics, and signal transduction in intestine of female chickens.
Larsson B; Nemere I
J Cell Biochem; 2003 Dec; 90(5):901-13. PubMed ID: 14624450
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
Choi M; Makishima M
Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor ligands for osteoporosis.
Cheskis BJ; Freedman LP; Nagpal S
Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
[TBL] [Abstract][Full Text] [Related]
20. TRPC3-like protein and vitamin D receptor mediate 1alpha,25(OH)2D3-induced SOC influx in muscle cells.
Santillán G; Katz S; Vazquez G; Boland RL
Int J Biochem Cell Biol; 2004 Oct; 36(10):1910-8. PubMed ID: 15203106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
